Cytek Biosciences Inc (CTKB)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 89,347 | 90,708 | 89,035 | 89,385 | 83,588 | 77,365 | 70,158 | 64,225 | 63,062 | 59,358 | 58,733 | 53,798 | 48,697 | 44,609 | 41,099 | 41,302 | 41,129 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $89,347K ÷ $—K
= —
The payables turnover ratio for Cytek Biosciences Inc is not available for the periods provided. The payables turnover ratio is a financial metric that indicates how efficiently a company pays its suppliers. A higher payables turnover ratio generally indicates that the company is paying its suppliers more quickly, which can sometimes be seen as a positive indicator. On the other hand, a very low payables turnover ratio may suggest that the company is taking too long to pay its suppliers, possibly indicating financial difficulties or strained relationships with vendors. Since the data for Cytek Biosciences Inc is unavailable, further analysis and comparison with industry averages or previous periods would be necessary to draw meaningful conclusions about their payables management efficiency.
Peer comparison
Dec 31, 2024